International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13853514
Original Research Article
Observational Study on the Prevalence and Outcomes of Gestational Diabetes Mellitus in a Tertiary Care Hospital
Published
Sept. 28, 2024
Abstract

Objective: To assess the prevalence of gestational diabetes mellitus (GDM) and evaluate the associated maternal and neonatal outcomes in a tertiary care hospital setting.Methods: This observational study included 180 pregnant women, of which 29 (16.1%) were diagnosed with GDM based on the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. Demographic and clinical data were collected, and maternal and neonatal outcomes were assessed.Results: The prevalence of GDM in the study population was 16.1%. Risk factors significantly associated with GDM included increasing age (OR: 1.10, 95% CI: 1.01-1.20, p=0.04), family history of diabetes (OR: 2.27, 95% CI: 1.03-5.00, p=0.04), higher BMI (OR: 1.12, 95% CI: 1.02- 1.23, p=0.02), and previous history of GDM (OR: 3.29, 95% CI: 1.01-10.73, p=0.049). Women with GDM had higher rates of cesarean delivery (51.7% vs. 33.8%), preeclampsia (17.2% vs. 7.3%), preterm delivery (20.7% vs. 11.9%), and neonatal hypoglycemia (17.2% vs. 6.0%, p=0.04) compared to those without GDM.Conclusion: The prevalence of GDM in this study was 16.1%, and several risk factors were identified. Women with GDM had higher rates of adverse maternal and neonatal outcomes, highlighting the importance of early screening and management of GDM.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
304 Views
128 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved